Metropolis Healthcare Q2 profit rises 43.2% to ₹75.3 crore
In short
Metropolis Healthcare said its Q2 net profit rose 43.2% year on year to ₹75.3 crore. Revenue increased 15.8% to ₹496.8 crore, and the company said patient volumes rose 10% while test volumes rose 11%.
The result looks strong for the company and its investors, and it also comes with an interim dividend of ₹1 per share. The reporting does not say whether the company changed its outlook.
What the reporting says
Metropolis Healthcare reported a 43.2% year-on-year rise in Q2 net profit to ₹75.3 crore, while revenue increased 15.8% to ₹496.8 crore. The company also said patient volumes rose 10%, test volumes rose 11%, specialty revenue grew 20%, and the board declared an interim dividend of ₹1 per share with November 9 as the record date. The reporting does not say whether guidance changed.
Why it matters
Metropolis Healthcare reported a strong Q2, with net profit up 43.2% to ₹75.3 crore and revenue up 15.8% to ₹496.8 crore. The company said higher patient and test volumes and 20% specialty revenue growth supported the result. It also declared an interim dividend of ₹1 per share, with November 9 as the record date. No guidance update was stated.